In this scenario, mounting evidence has suggested that the activation of Nrf2-ARE signaling pathway plays a role in the improvement of chronic inflammation involved in several autoimmune, autoinflammatory, metabolic, infectious, neurodegenerative diseases, and in cancer (Hennig et al., 2018). The gene discussed is NFE2L2; the disease is cancer.